Clinical Trials List
2025-06-01 - 2028-05-31
Phase III
Recruiting11
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 黃怡菁 Division of Hematology & Oncology
- 魏慈慧 無
- Jui-Hung Tsai Division of Hematology & Oncology
- 黃怡璇 無
- Chun-Hui Lee Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Zhu-Jun Loh 無
- Shang-Hung Chen Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張端瑩 Division of Hematology & Oncology
- YEN-SHEN LU 無
- 李宜軒 Division of Others
- 陳怡君 Division of Hematology & Oncology
- 楊明翰 無
- MING-YANG WANG Division of General Surgery
- 郭文宏 無
- 黃柏翔 Division of Hematology & Oncology
- 羅喬 無
- 林柏翰 Division of General Internal Medicine
- Wei-Wu Chen Division of Hematology & Oncology
- 蔡立威 無
- 陳怡君 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Yu Hsieh Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
- 蘇智銘 Division of General Surgery
- HUI-WEN LIU Division of Hematology & Oncology
- KA-WAI TAM Division of General Surgery
- 廖立民 Division of General Surgery
- Wei-Hong Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱仁輝 無
- 馮晉榮 Division of General Surgery
- Yi-Fang Tsai 無
- 陳柏方 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 賴亦貞 無
- 陳彥蓁 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 鄭涵方 無
- 林燕淑 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- Jiun-I Lai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Li-Yu Lee Division of Others -
- Yung-Chang Lin Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- 沈士哲 無
- Wen-Ling Kuo 無
- Chan-Keng Yang Division of Hematology & Oncology
- 周旭桓 無
- Mengting Peng 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HWEI-CHUNG WANG Division of General Surgery
- 黃至豪 Division of General Surgery
- Yao-Chung Wu Division of General Surgery
- Chih-Jung Chen 無
- Chen-Teng Wu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 甘蓉瑜 無
- Shen Liang Shih 無
- Junping Shiau Shiau 無
- Chung-Liang Li 無
- Chieh-Han Chuang 無
- Fang-Ming Chen 無
- 巫承哲 無
- 高理鈞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
67 participants
-
Global
380 participants
